公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations | Wu J.-Y.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Medicine | 32 | 27 | |
2005 | Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status | Su W.-P.; CHIH-HSIN YANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; CHIUN HSU ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 12 | 10 | |
2008 | Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial | CHIUN HSU ; SUNG-HSIN KUO ; Hu F.-C.; ANN-LII CHENG ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIA-CHI LIN ; Huang T.-C.; PAN-CHYR YANG ; CHIH-HSIN YANG | Lung Cancer | 14 | 11 | |
2012 | Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum | WEI-YU LIAO ; JIN-YUAN SHIH ; Chang G.-C.; Cheng Y.-K.; CHIH-HSIN YANG ; Chen Y.-M.; CHONG-JEN YU | Journal of Thoracic Oncology | 50 | 50 | |
2001 | Global analysis of gene expression in invasion by a lung cancer model | Chen J.J.W.; Peck K.; Hong T.-M.; Yang S.-C.; Sher Y.-P.; JIN-YUAN SHIH ; Wu R.; Cheng J.-L.; Roffler S.R.; Wu C.-W.; PAN-CHYR YANG | Cancer Research | 175 | 162 | |
2010 | Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation | YAO-WEN KUO ; SHANG-GIN WU ; CHAO-CHI HO ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 73 | 67 | |
2008 | Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern | SHANG-GIN WU ; YIH-LEONG CHANG ; Hsu Y.-C.; Wu J.-Y.; CHIH-HSIN YANG ; CHONG-JEN YU ; Tsai M.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | Oncologist | 72 | 67 | |
2011 | Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations | SHANG-GIN WU ; CHIH-HSIN YANG ; CHONG-JEN YU ; JIH-HSIANG LEE ; Hsu Y.-C.; YIH-LEONG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung Cancer | 41 | 35 | |
2010 | Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women | TZU-PIN LU ; Tsai, M.-H.; JANG-MING LEE ; Hsu, C.-P.; Chen, P.-C.; CHUNG-WU LIN ; JIN-YUAN SHIH ; PAN-CHYR YANG ; CHUHSING KATE HSIAO ; LIANG-CHUAN LAI ; ERIC YAO-YU CHUANG | Cancer Epidemiology Biomarkers and Prevention | 249 | 234 | |
2015 | Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan | Hsu K.-H.; CHAO-CHI HO ; Hsia T.-C.; Tseng J.-S.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Chang G.-C. | PLoS ONE | 98 | 92 | |
2019 | IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer | SHANG-GIN WU ; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU ; YIH-LEONG CHANG ; CHONG-JEN YU ; JIN-YUAN SHIH | Cancers | 15 | 12 | |
2015 | IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer | Liu Y.-N.; Chang T.-H.; Tsai M.-F.; SHANG-GIN WU ; TZU-HSIU TSAI ; Chen H.-Y.; SUNG-LIANG YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Oncotarget | 57 | 56 | |
2019 | The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer | YEN-TING LIN ; Liu Y.-N.; JIN-YUAN SHIH | Frontiers in Oncology | 10 | 8 | |
2019 | Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients | ZONG-HAN YAO ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; ZHONG-ZHE LIN ; CHIA-CHI LIN ; CHIH-HSIN YANG ; CHONG-JEN YU | European Journal of Cancer | 27 | 24 | |
2011 | Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction | SHANG-GIN WU ; YIH-LEONG CHANG ; JOU-WEI LIN ; CHEN-TU WU ; Chen, Hsuan-Yu; Tsai, Meng-Feng; Lee, Yung-Chie; CHONG-JEN YU ; JIN-YUAN SHIH | PloS one | 49 | 43 | |
2015 | Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer | TZU-TANG WEI ; Lin, Yu-Chin; Lin, Pei-Hua; JIN-YUAN SHIH ; Chou, Chia-Wei; Huang, Wei-Jan; Yang, Yu-Chih; Hsiao, Pei-Wen; CHING-CHOW CHEN | Oncotarget | 12 | 12 | |
2010 | Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer | Wu J.-Y.; CHONG-JEN YU ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; PAN-CHYR YANG | Lung Cancer | 19 | 18 | |
2008 | Leg pains, clubbing of digits and lung mass: What is your call? | Wu J.-Y.; JIN-YUAN SHIH | CMAJ | 3 | 3 | |
2023 | LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis | Chen, Yi-Ling; Liu, Yi-Nan; YEN-TING LIN ; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; CHIA-LANG HSU ; HUEY-DONG WU ; JIN-YUAN SHIH | Journal of biomedical science | 2 | 0 | |
2022 | The Long-Term and Mediating Effects of Mindfulness Integrated with Body-Mind-Spirit Group Therapy on Depressive Symptoms and Quality of Life Among Non-small Cell Lung Cancer Patients | FEI-HSIU HSIAO ; ZHONG-ZHE LIN ; Huang F.-Y.; Lai Y.-M.; Chen Y.-T.; JIN-YUAN SHIH ; CHAO-CHI HO ; CHONG-JEN YU ; Hsieh C.-C. | Mindfulness | 1 | 1 | |